Physician profile
Staci W Kell
NPI 1528084282
$1,343.48
in general payments reported to CMS, 2019-2025
19 companies · $21.40 in 2025
The $21.40 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $395 · 2022: $310 · 2023: $493 · 2024: $125 · 2025: $21.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $639.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $639.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $524.18 | 2021-2023 | |
| Lilly USA, LLC | $208.04 | 2021-2024 | Zepbound |
| Novo Nordisk INC | $139.94 | 2021-2023 | Wegovy, Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $62.64 | 2021-2023 | Shingrix, Arexvy |
| Astellas Pharma US INC | $40.23 | 2023 | Myrbetriq |
| Horizon Therapeutics Plc | $39.05 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.81 | 2021-2022 | |
| Amgen INC. | $35.82 | 2022-2023 | Evenity, Prolia |
| Novartis Pharmaceuticals Corporation | $34.96 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $33.14 | 2021 | |
| Sumitomo Pharma America, INC. | $32.12 | 2023 | Gemtesa |
| E.R. Squibb & Sons, L.L.C. | $28.37 | 2023 | Camzyos, Eliquis |
| Pfizer INC. | $28.23 | 2021 | |
| Medtronic, INC. | $21.40 | 2025 | Inceptiv |
| Otsuka America Pharmaceutical, INC. | $19.37 | 2023 | Rexulti |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $18.57 | 2021 | |
| Exact Sciences Corporation | $14.46 | 2023 | Cologuard Collection Kit |
| Sunovion Pharmaceuticals INC. | $13.22 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.93 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Staci Kell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.